Charles A. Boucher
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts.
Journal: Scientific reports
Published: June 05, 2019
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 22, 2019
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
Journal: Journal of the International AIDS Society
Published: May 09, 2019
The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C.
Journal: Journal of virus eradication
Published: July 28, 2018
State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps.
Journal: AIDS reviews
Published: April 10, 2018
State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.
Journal: AIDS reviews
Published: April 10, 2018
The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors.
Journal: The Journal of infectious diseases
Published: November 22, 2017
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 28, 2017
Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.
Journal: Antiviral therapy
Published: February 25, 2017
Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir.
Journal: Case reports in infectious diseases
Published: May 30, 2015
Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS).
Journal: Antiviral therapy
Published: March 27, 2015
Last Updated: 09/26/2026